The Asia Pacific Bionic Eye Market is expected to witness market growth of 15.3% CAGR during the forecast period (2020-2026).
Factors like the increasing incidence of diseases related to the eyesight, increasing prevalence of diseases such as diabetes, heart attacks, etc. along with technological development are contributing to the market growth. As treatment is very costly, so it may hamper the growth of the market. Bionics is also referred to as biomedical implants that are artificial devices added to the body. The artificial implants restore the normal functioning of the lost or non-functional body parts. The rise in the geriatric population, an increase in the number of patients suffering from chronic diseases, and the government’s attention to funding R&D initiatives are likely to drive the growth of the market. Though, the high cost of the bionic devices and treatment is expensive in addition to its stringent approval process for such devices that are anticipated to hinder the market growth.
A visual prosthesis also referred to as a bionic eye, is a new visual device proposed to restore the functional vision of the defected eye of the patient who has lost complete or partial vision of the eye. Many such devices have developed from the past few years, such as the cochlear implant, bionic ear devices, on the basis of this model, visual prosthetics have been developed as a possibly valuable aid for individuals who suffer from the loss of eyesight.
Based on Technology, the market is segmented into Electronic and Mechanical. Based on End Use, the market is segmented into Hospitals, Eye Clinics and Other End uses. Based on Type, the market is segmented into Implanted Eye and External Eye. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Second Sight Medical Products, Inc., Pixium Vision S.A., Nidek Co., Ltd., Optobionics Corporation, Biomedical Technologies S.L., Bionic Vision Technologies Pty. Ltd., Monash Vision Group, The Bionic Eye (The Bionic Group), Nano Retina Ltd. and iBionics.
Scope of the Study
Market Segmentation:
By Technology
By End Use
By Type
By Country
Companies Profiled
Unique Offerings from the Publisher
Factors like the increasing incidence of diseases related to the eyesight, increasing prevalence of diseases such as diabetes, heart attacks, etc. along with technological development are contributing to the market growth. As treatment is very costly, so it may hamper the growth of the market. Bionics is also referred to as biomedical implants that are artificial devices added to the body. The artificial implants restore the normal functioning of the lost or non-functional body parts. The rise in the geriatric population, an increase in the number of patients suffering from chronic diseases, and the government’s attention to funding R&D initiatives are likely to drive the growth of the market. Though, the high cost of the bionic devices and treatment is expensive in addition to its stringent approval process for such devices that are anticipated to hinder the market growth.
A visual prosthesis also referred to as a bionic eye, is a new visual device proposed to restore the functional vision of the defected eye of the patient who has lost complete or partial vision of the eye. Many such devices have developed from the past few years, such as the cochlear implant, bionic ear devices, on the basis of this model, visual prosthetics have been developed as a possibly valuable aid for individuals who suffer from the loss of eyesight.
Based on Technology, the market is segmented into Electronic and Mechanical. Based on End Use, the market is segmented into Hospitals, Eye Clinics and Other End uses. Based on Type, the market is segmented into Implanted Eye and External Eye. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Second Sight Medical Products, Inc., Pixium Vision S.A., Nidek Co., Ltd., Optobionics Corporation, Biomedical Technologies S.L., Bionic Vision Technologies Pty. Ltd., Monash Vision Group, The Bionic Eye (The Bionic Group), Nano Retina Ltd. and iBionics.
Scope of the Study
Market Segmentation:
By Technology
- Electronic
- Mechanical
By End Use
- Hospitals
- Eye Clinics
- Other End uses
By Type
- Implanted Eye
- External Eye
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Second Sight Medical Products, Inc.
- Pixium Vision S.A.
- Nidek Co., Ltd.
- Optobionics Corporation
- Biomedical Technologies S.L.
- Bionic Vision Technologies Pty. Ltd.
- Monash Vision Group
- The Bionic Eye (The Bionic Group)
- Nano Retina Ltd.
- iBionics
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Bionic Eye Market by Technology
Chapter 4. Asia Pacific Bionic Eye Market by End-use
Chapter 5. Asia Pacific Bionic Eye Market by Type
Chapter 6. Asia Pacific Bionic Eye Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Second Sight Medical Products, Inc.
- Pixium Vision S.A.
- Nidek Co., Ltd.
- Optobionics Corporation
- Biomedical Technologies S.L.
- Bionic Vision Technologies Pty. Ltd.
- Monash Vision Group
- The Bionic Eye (The Bionic Group)
- Nano Retina Ltd.
- iBionics
Methodology
LOADING...
